COMMUNIQUÉS West-GlobeNewswire

-
CV Sciences Comments on FDA CBD Hearing
06/06/2019 -
Novan Achieves Compliance with Nasdaq Listing Rule 5450(b)(2)(A)
06/06/2019 -
Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2019 Financial Results on August 9, 2019
06/06/2019 -
Establishment Labs Announces Appointment of Lisa Gersh to Board of Directors
06/06/2019 -
Xeris Pharmaceuticals Receives Notification of PDUFA Date Extension for Gvoke™
06/06/2019 -
NHL player Max Domi walks with thousands of Montrealers to find a cure for type 1 diabetes
06/06/2019 -
Max Domi, joueur de la LNH, marchera avec des milliers de résidents du Grand Montréal pour trouver une guérison au diabète de type 1
06/06/2019 -
Over 35,000 Canadians from coast to coast rally to find a cure for type 1 diabetes
06/06/2019 -
Aeterna Zentaris Provides Corporate Update
06/06/2019 -
Company announcement
06/06/2019 -
Oxurion NV - Data from a Phase 1/2 Clinical Study evaluating THR-317 (anti-PlGF) for DME presented at 2019 FLORetina Meeting
06/06/2019 -
Eloxx Pharmaceuticals Presents Positive New Data for Lead Investigational Drug, ELX-02, at the 42nd European Cystic Fibrosis Society Conference (ECFS)
06/06/2019 -
IBA - Transparency Notification
06/06/2019 -
IBA - Publication relative à une notification de transparence
06/06/2019 -
Aleafia Health Announces $35 Million Public Offering of 8.5% Convertible Debenture Units
06/06/2019 -
Innovation Pharmaceuticals Signs Agreement for Advanced Oral Tablet Technology in Treating Inflammatory Bowel Disease
06/06/2019 -
Konica Minolta Healthcare Announces Autologous Biologics Workshop in Partnership with EmCyte Corporation
06/06/2019 -
Medifirst Solutions Gets Approval for Merchant Account for Hemp and CBD Products
06/06/2019 -
Chiesi Group is the largest pharmaceutical group in the world to be awarded B Corp certification
06/06/2019
Pages